drugset / Trial / NCT04615351

A Pragmatic Approach to Lowering the Risk of Diabetes Mellitus After A Diagnosis of Gestational Diabetes Mellitus

NCT04615351 ↗

Phase 3 Unknown 200 enrolled Women and Infants Hospital of Rhode Island
RandomizedParallel-groupSingle-blindPrevention

Summary

A Pilot of Metformin Postpartum

Timeline

Start
2020-11-15
Primary completion
2021-10-31
Completion
2022-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 1000 mg Oral

Indications